A Drug By Any Other Name (Part 2)

A Drug By Any Other Name (Part 2)

Issue #23 May 2023

In the previous issue of this newsletter, I talked about how drug companies don’t usually call their products “drugs” or even refer to the type of drug they produce or sell. Alcohol and tobacco companies emphasize…

A Drug By Any Other Name (Part 2)

A Drug By Any Other Name (Part 1)

Issue #22  April 2023

[This is a modified excerpt from “Buzz Kill: The Corporatization of Cannabis”.
https://blackrosebooks.com/products/buzz-kill-michael-r-devillaer ]

“I am, by calling, a dealer in words; and words are, of course, the most powerful drug used by mankind.”

 – Rudyard Kipling

A Drug By Any Other Name (Part 2)

Buzz Kill: The Corporatization of Cannabis – What’s It All About?

Issue # 21 March 2023

Black Rose Books has announced that my book Buzz Kill: The Corporatization of Cannabis will be part of its spring release. I appreciate that those of you who pre-ordered it have been waiting patiently. As an expression of gratitude, I am using this issue of Drug Policy Alternatives to leak a sample of the book’s content.

A Drug By Any Other Name (Part 2)

Canadian Cannabis Industry Woes: The Bigger Picture

Issue #20    February 2023

Perhaps hoping for some lingering love from Valentine’s Day, the beleaguered cannabis industry once again took its case to a public forum. In a February 15th presser, its latest appeal focuses on the inability of industry to make a profit under the yoke of taxation and its frustration in competing with the illegal market.

A Drug By Any Other Name (Part 2)

Flight & Fight: Low Risk Alcohol Consumption & Product Warning Labels

Includes excerpts from
Buzz Kill: The Corporatization of Cannabis
Issue #19 January 2023

This issue of Drug Policy Alternatives addresses the currently heightened attention to the risks of alcohol consumption. The attention has arisen from the release of revised low risk drinking guidelines from the Canadian Centre for Substance Use and Addiction (CCSA).

A Drug By Any Other Name (Part 2)

Drugs: A Mosaic of Contradictions

Sample from
Buzz Kill: The Corporatization of Cannabis
Issue #18 December 2022

Legal industries for alcohol, tobacco, and pharmaceutical products are older than any of us. We have known them only as mature, adult industries and must read about their birth and early development. The legalization of cannabis—the creation of a new legal drug industry—is an unprecedented experience for Canadians, and increasingly, for the people of other nations.